| scholarly article | Q13442814 |
| P50 | author | Michael C. Neale | Q55622998 |
| Kenneth Kendler | Q6390313 | ||
| P2093 | author name string | Prescott CA | |
| Karkowski LM | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 261-269 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins | |
| P478 | volume | 57 |
| Q35764721 | "Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs |
| Q37157322 | A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence |
| Q36535515 | A Primer on the Genetics of Comorbid Eating Disorders and Substance Use Disorders |
| Q33562500 | A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use |
| Q36345352 | A family history of substance dependence obscures the group differences in brain function associated with HIV-1 and ART. |
| Q93141972 | A genome-wide association study of cocaine use disorder accounting for phenotypic heterogeneity and gene–environment interaction |
| Q35842989 | A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. |
| Q44448289 | A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence |
| Q51918324 | A longitudinal study of personality and major depression in a population-based sample of male twins. |
| Q55496434 | A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction. |
| Q48297517 | A pilot study of life events and mood disorders: self-report survey in chinese heroin-dependent individuals |
| Q35607184 | A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men. |
| Q57170032 | A review of opioid addiction genetics |
| Q27312296 | A review of pharmacogenetic studies of substance-related disorders |
| Q31926110 | A twin study on sensation seeking, risk taking behavior and marijuana use. |
| Q37212865 | ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure |
| Q22337278 | Addiction and the brain: The neurobiology of compulsion and its persistence |
| Q46892867 | Age at first intoxication and alcohol use disorders in Southwest California Indians |
| Q35194488 | Alcohol dependence in men: reliability and heritability |
| Q35738065 | Amphetamine self-administration and dopamine function: assessment of gene × environment interactions in Lewis and Fischer 344 rats |
| Q52300747 | Analysis of dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts. |
| Q46196495 | Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence |
| Q99629780 | Anxiety and Depression among Amphetamine-Type Stimulant Users: The Association with Religiosity and Religious Coping |
| Q42577811 | Are addictions diseases or choices? |
| Q35828042 | Are the symptoms of cannabis use disorder best accounted for by dimensional, categorical, or factor mixture models? A comparison of male and female young adults |
| Q42821693 | Are there guidelines for the responsible prescription of benzodiazepines? |
| Q34980182 | Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence |
| Q36973407 | Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence |
| Q35609885 | Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome |
| Q34518693 | Association of substance dependence phenotypes in the COGA sample |
| Q36463511 | Association of the Neuronal Cell Adhesion Molecule (NrCAM) Gene Variants with Personality Traits and Addictive Symptoms in Methamphetamine Use Disorder |
| Q48252879 | Association study of 37 genes related to serotonin and dopamine neurotransmission and neurotrophic factors in cocaine dependence. |
| Q37576232 | Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population |
| Q35085285 | Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study |
| Q64941989 | Benzodiazepine use, misuse, and abuse: A review. |
| Q35060322 | Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes |
| Q37245382 | Candidate genes for cannabis use disorders: findings, challenges and directions |
| Q45352449 | Candidate pathway association study in cocaine dependence: the control of neurotransmitter release |
| Q33585794 | Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability |
| Q36930929 | Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents |
| Q47328661 | Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism |
| Q34321283 | Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study |
| Q36431241 | Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations |
| Q36881320 | Case-control association study of WLS variants in opioid and cocaine addicted populations. |
| Q93097750 | Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry |
| Q33946544 | Clinical features of drug abuse that reflect genetic risk |
| Q33625523 | Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory |
| Q55010732 | Collaborative Phenotype Inference from Comorbid Substance Use Disorders and Genotypes. |
| Q34952494 | Common genetic contributions to alcohol and cannabis use and dependence symptomatology |
| Q24603044 | Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective |
| Q35613203 | Considerations of elder sibling closeness in predicting younger sibling substance use: social learning versus social bonding explanations |
| Q45063435 | Contributions of Genes and Environment to Developmental Change in Alcohol Use. |
| Q34581944 | Creating a social world: a developmental twin study of peer-group deviance |
| Q36801392 | Cross-generational transmission from drug abuse in parents to attention-deficit/hyperactivity disorder in children |
| Q34532410 | Current evolutionary adaptiveness of psychiatric disorders: Fertility rates, parent-child relationship quality, and psychiatric disorders across the lifespan |
| Q56805570 | DEMONSTRATING THE VALIDITY OF TWIN RESEARCH IN CRIMINOLOGY |
| Q36874680 | Decision making in the pathway from genes to psychiatric and substance use disorders |
| Q40209149 | Differences in cannabis-related experiences between patients with a first episode of psychosis and controls. |
| Q42152682 | Dopamine-beta hydroxylase polymorphism and cocaine addiction |
| Q36658120 | Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. |
| Q33624714 | EEG spectral phenotypes: heritability and association with marijuana and alcohol dependence in an American Indian community study |
| Q30373359 | Endocannabinoid signalling in reward and addiction. |
| Q35907793 | Environmental clustering of drug abuse in households and communities: multi-level modeling of a national Swedish sample |
| Q37238707 | Environmental influences on familial resemblance for drug abuse in first-cousin pairs: a Swedish national study |
| Q49912035 | Environmental, genetic and epigenetic contributions to cocaine addiction |
| Q34250653 | Epidemiology of substance use disorders |
| Q34090556 | Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome |
| Q36050631 | Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis |
| Q36703004 | Evidence for a genetic component for substance dependence in Native Americans. |
| Q34980334 | Family history density predicts long term substance use outcomes in an adolescent treatment sample |
| Q37609334 | Four factors for the initiation of substance use by young adulthood: a 10-year follow-up twin and sibling study of marital conflict, monitoring, siblings, and peers |
| Q35571722 | Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis |
| Q35607202 | Gambling, disordered gambling and their association with major depression and substance use: a web-based cohort and twin-sibling study |
| Q35950888 | Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability |
| Q34076144 | Genes and addiction |
| Q40644644 | Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins |
| Q33750946 | Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood |
| Q33805566 | Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies |
| Q36817540 | Genetic and environmental predictors of latent trajectories of alcohol use from adolescence to adulthood: a male twin study |
| Q37484709 | Genetic and environmental risk factors for illicit substance use and use disorders: Joint analysis of self and co-twin ratings |
| Q42602423 | Genetic and environmental risk factors in adolescent substance use. |
| Q34258984 | Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study |
| Q37591202 | Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study |
| Q36071808 | Genetic factors modulating the response to stimulant drugs in humans |
| Q36828742 | Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence |
| Q34498477 | Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders |
| Q44367442 | Genetic variation in the psychomotor stimulant properties of cocaine in Mus musculus |
| Q34347033 | Genetically informative research on adolescent substance use: methods, findings, and challenges |
| Q35978336 | Genetics and drug use as a complex phenotype |
| Q34139876 | Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence |
| Q35237159 | Genetics of drug dependence |
| Q33526292 | Genome wide association for addiction: replicated results and comparisons of two analytic approaches |
| Q33394394 | Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples |
| Q35969360 | Genome-environmental risk assessment of cocaine dependence |
| Q36968466 | Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers |
| Q37254570 | Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes |
| Q34580817 | Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement |
| Q28741033 | Genome-wide association study in bipolar patients stratified by co-morbidity |
| Q37397180 | Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene |
| Q37393114 | Genome-wide linkage analysis of heroin dependence in Han Chinese: results from Wave Two of a multi-stage study |
| Q36926083 | Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study |
| Q33982861 | Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence |
| Q25255604 | Genomic screen for loci associated with tobacco usage in Mission Indians |
| Q36042323 | Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry |
| Q46384933 | Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder. |
| Q33772486 | Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community |
| Q36111897 | Heritability of cannabis initiation in Dutch adult twins |
| Q35933363 | Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins |
| Q44546878 | Impaired emotional facial expression recognition in alcoholics, opiate dependence subjects, methadone maintained subjects and mixed alcohol-opiate antecedents subjects compared with normal controls. |
| Q51971297 | Implications of genetic epidemiology for the prevention of substance use disorders. |
| Q34358797 | Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? |
| Q44340859 | Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence |
| Q34630738 | Is there heterogeneity among syndromes of substance use disorder for illicit drugs? |
| Q34133171 | Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study |
| Q34555160 | Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions |
| Q44772555 | Linking substance use and problem behavior across three generations |
| Q37247145 | Longitudinal modeling of genetic and environmental influences on self-reported availability of psychoactive substances: alcohol, cigarettes, marijuana, cocaine and stimulants |
| Q33865218 | Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. |
| Q91102352 | Marriage and reductions in men's alcohol, tobacco, and cannabis use |
| Q73266739 | Maternal Correlates of Toddler Insecure and Dependent Behavior |
| Q37079307 | Measured environmental contributions to cannabis abuse/dependence in an offspring of twins design |
| Q33750905 | Modeling the genetic and environmental association between peer group deviance and cannabis use in male twins |
| Q37380997 | Moderators of the association between peer and target adolescent substance use. |
| Q30432964 | Mouse models for studying genetic influences on factors determining smoking cessation success in humans |
| Q36730570 | Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant |
| Q52315766 | Neuroepigenetics and addiction. |
| Q37492566 | Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans |
| Q36335668 | Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior |
| Q44557822 | Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. |
| Q28269117 | NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice |
| Q28082706 | Opioids in pregnancy and neonatal abstinence syndrome |
| Q35439069 | Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans |
| Q46727440 | P3 components of the event-related potential and marijuana dependence in Southwest California Indians |
| Q37148500 | Pathways from earlier marijuana use in the familial and non-familial environments to self-marijuana use in the fourth decade of life. |
| Q33750925 | Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse |
| Q34116570 | Pharmacogenomics and addiction to opiates |
| Q36039402 | Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. |
| Q35011938 | Predicting alcohol consumption in adolescence from alcohol-specific and general externalizing genetic risk factors, key environmental exposures and their interaction |
| Q34626957 | Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence |
| Q34114684 | Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence |
| Q35211165 | Psychometric modeling of cannabis initiation and use and the symptoms of cannabis abuse, dependence and withdrawal in a sample of male and female twins |
| Q37021009 | Psychopathology in offspring from multiplex alcohol dependence families with and without parental alcohol dependence: a prospective study during childhood and adolescence |
| Q28209521 | Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors |
| Q37254797 | Role of endocannabinoid signaling in anxiety and depression |
| Q44641835 | Salvia divinorum use and phenomenology: results from an online survey |
| Q37160674 | Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment |
| Q52281090 | Sedative use and misuse in the United States. |
| Q39370565 | Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center |
| Q35126986 | Sex differences and developmental stability in genetic and environmental influences on psychoactive substance consumption from early adolescence to young adulthood |
| Q35957455 | Shared environmental contributions to substance use. |
| Q28476270 | Symbiotic relationship of pharmacogenetics and drugs of abuse. |
| Q37149613 | The Genetic and Environmental Association Between Parental Monitoring and Risk of Cannabis, Stimulants, and Cocaine Initiation in a Sample of Male Twins: Does Parenting Matter? |
| Q41525356 | The Genomics of Neonatal Abstinence Syndrome |
| Q36154550 | The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach |
| Q34809059 | The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study |
| Q35874997 | The association between speed of transition from initiation to subsequent use of cannabis and later problematic cannabis use, abuse and dependence |
| Q34084164 | The causal nature of the association between neighborhood deprivation and drug abuse: a prospective national Swedish co-relative control study |
| Q34514187 | The causes of parent-offspring transmission of drug abuse: a Swedish population-based study |
| Q40407306 | The differential impact of risk factors on illicit drug involvement in females |
| Q33579769 | The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction |
| Q24607129 | The genetic basis of addictive disorders |
| Q36135947 | The genetics of addiction-a translational perspective |
| Q34431107 | The genetics of addictions: uncovering the genes |
| Q36434454 | The moderating effect of parental illicit substance use disorders on the relation between adolescent depression and subsequent illicit substance use disorders |
| Q34463974 | The pharmacogenetics of alcohol use disorder |
| Q34720120 | The prevention of gambling problems in youth: a conceptual framework |
| Q36757752 | The rearing environment and risk for drug abuse: a Swedish national high-risk adopted and not adopted co-sibling control study |
| Q28238267 | The role of the habenula in drug addiction. |
| Q33624939 | Tobacco, cannabis, and other illicit drug use among Finnish adolescent twins: causal relationship or correlated liabilities? |
| Q37381132 | Trajectory of adolescent cannabis use on addiction vulnerability |
| Q37058649 | Transcriptomic and genetic studies identify NFAT5 as a candidate gene for cocaine dependence |
| Q36234326 | Two-part random effects growth modeling to identify risks associated with alcohol and cannabis initiation, initial average use and changes in drug consumption in a sample of adult, male twins |
| Q24601922 | Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes |
| Q36720099 | Within-family environmental transmission of drug abuse: a Swedish national study |
Search more.